Showing results (421-430 of 139,818) with videos related to
Sort By:
Pageof 13,982
Journal of the American Society of Nephrology : JASN|February 22, 2002
Chemokine receptor polymorphism and risk of acute rejection in human renal transplantationReza Abdi, Tran Thi Bich Huong, Alfredo Sahagun-Ruiz, et al.Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|November 1, 2011
Rituximab associated neutropenia: description of three cases and an insight into the underlying pathogenesisAlina Weissmann-Brenner, Baruch Brenner, Inessa Belyaeva, et al.Gynecologic Oncology|June 1, 1986
Abdominopelvic irradiation for stage II-IV ovarian carcinoma patients with limited or no residual disease at second-look laparotomy after completion of cisplatinum-based combination chemotherapyJ Menczer, M Modan, J Brenner, et al.Journal of Athletic Training|January 1, 2014
Experiences and attitudes of collegiate athletic trainers regarding alcohol-related unintentional injury in athletesJames W Brenner, Stacie M Metz, Jack Entriken, et al.Clinical Orthopaedics and Related Research|March 8, 2012
Beyond the standard of care: a new model to judge medical negligenceLawrence H Brenner, Alison Tytell Brenner, Eric J Awerbuch, et al.Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry|April 21, 2012
Nanomaterial-based treatments for medical device-associated infectionsNhiem Tran, Phong A TranGynecologic Oncology|February 1, 1984
A comparison of postoperative radiotherapy with postoperative chemotherapy in stage II-IV ovarian cancer patientsJ Menczer, G Ben-Baruch, M Modan, et al.American Journal of Obstetrics and Gynecology|November 1, 1986
A comparison of low- and high-dose cisplatin-based combination chemotherapy as initial postoperative treatment in advanced ovarian adenocarcinomaJ Menczer, J Brenner, M Modan, et al.P & T : a Peer-Reviewed Journal for Formulary Management|March 28, 2014
Olmesartan and drug-induced enteropathyTran H Tran, Hanlin LiP & T : a Peer-Reviewed Journal for Formulary Management|March 28, 2014
New oral anticoagulants for atrial fibrillation: are they worth the risk?Hira Shafeeq, Tran H TranPageof 13,982